Prof Ken Walder

Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder

T Truong, Z Liu, B Panizzutti, O Dean, M Berk, J Kim, K Walder

(2024), Vol. 350, pp. 230-239, Journal of Affective Disorders, Netherlands, C1

Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity

L Hall, J Czeczor, T Connor, J Botella, K De Jong, M Renton, A Genders, K Venardos, S Martin, S Bond, K Aston-Mourney, K Howlett, J Campbell, G Collier, K Walder, M McKenzie, M Ziemann, S McGee

(2024), Vol. 15, pp. 1-13, Nature Communications, London, Eng., C1

Network-based drug repurposing for schizophrenia

T Truong, Z Liu, B Panizzutti, J Kim, O Dean, M Berk, K Walder

(2024), Neuropsychopharmacology, C1

The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model

Z Liu, T Truong, C Bortolasci, B Spolding, B Panizzutti Parry, C Swinton, J Kim, D Hernández, S Kidnapillai, L Gray, M Berk, O Dean, K Walder

(2024), Molecular Psychiatry, Berlin, Germany, C1

Metformin is Protective Against the Development of Mood Disorders

J Lake, C Bortolasci, A Stuart, J Pasco, S Kidnapillai, B Spolding, T Truong, B Panizzutti, Z Liu, O Dean, T Crowley, M Richardson, J Kim, M Berk, L Williams, K Walder

(2023), Vol. 56, pp. 25-31, Pharmacopsychiatry, C1

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response

A Walker, M Mohebbi, M Maes, M Berk, K Walder, C Bortolasci, Z Liu, C Ng, M Ashton, L Berk, A Singh, G Malhi, O Dean

(2023), Vol. 27, Brain, Behavior, and Immunity - Health, C1

Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes

S Sithara, T Crowley, K Walder, K Aston-Mourney

(2023), Vol. 15, pp. 2165368-, Islets, United States, C1

Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis

S Halstead, D Siskind, M Amft, E Wagner, V Yakimov, Z Shih-Jung Liu, K Walder, N Warren

(2023), Vol. 10, pp. 260-271, The Lancet Psychiatry, Amsterdam, The Netherlands, C1-1

Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression

C Bortolasci, S Kidnapillai, B Spolding, T Truong, T Connor, C Swinton, B Panizzutti, Z Liu, A Sanigorski, O Dean, T Crowley, M Richardson, K Bozaoglu, K Vlahos, S Cowdery, B Watmuff, S Steyn, D Wolmarans, B Engelbrecht, C Perry, K Drummond, T Pang, S Jamain, L Gray, S McGee, B Harvey, J Kim, M Leboyer, M Berk, K Walder

(2023), Vol. 25, pp. 661-670, Bipolar Disorders, C1

Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis

B Panizzutti, D Skvarc, S Lin, S Croce, A Meehan, C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean

(2023), Vol. 24, International Journal of Molecular Sciences, C1-1

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine

S Khanra, P Reddy, A Giménez-Palomo, C Park, B Panizzutti, M McCallum, S Arumugham, S Umesh, M Debnath, B Das, G Venkatasubramanian, M Ashton, A Turner, O Dean, K Walder, E Vieta, L Yatham, I Pacchiarotti, Y Reddy, N Goyal, M Kesavan, L Colomer, M Berk, J Kim

(2023), Vol. 28, pp. 3231-3242, Molecular Psychiatry, C1

Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance

S Masson, S Madsen, K Cooke, M Potter, A Vegas, L Carroll, S Thillainadesan, H Cutler, K Walder, G Cooney, G Morahan, J Stöckli, D James

(2023), Vol. 12, pp. 1-28, eLife, Cambridge, Eng., C1

A plasma protein signature associated with cognitive function in men without severe cognitive impairment

K Mehta, M Mohebbi, J Pasco, L Williams, S Sui, K Walder, B Ng, V Gupta

(2023), Vol. 15, pp. 1-13, Alzheimer's Research and Therapy, London, Eng., C1

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

M Berk, O Köhler-Forsberg, M Turner, B Penninx, A Wrobel, J Firth, A Loughman, N Reavley, J McGrath, N Momen, O Plana-Ripoll, A O'Neil, D Siskind, L Williams, A Carvalho, L Schmaal, A Walker, O Dean, K Walder, L Berk, S Dodd, A Yung, W Marx

(2023), Vol. 22, pp. 366-387, World Psychiatry, London, Eng., C1-1

CaMKK2 as an emerging treatment target for bipolar disorder

J Kaiser, K Nay, C Horne, L McAloon, O Fuller, A Muller, D Whyte, A Means, K Walder, M Berk, A Hannan, J Murphy, M Febbraio, A Gundlach, J Scott

(2023), pp. 1-12, Molecular Psychiatry, Berlin, Germany, C1

Impact of Mood Disorder History and Bone Health on Cognitive Function Among Men Without Dementia

Kanika Mehta, Mohammadreza Mohebbi, Julie Pasco, Lana Williams, Ken Walder, Boon Ng, Veer Gupta

(2023), pp. 1-13, Journal of Alzheimer's Disease, Netherlands, C1

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

C Bortolasci, E Jaehne, D Hernández, B Spolding, T Connor, B Panizzutti, O Dean, T Crowley, A Yung, L Gray, J Kim, M van den Buuse, M Berk, K Walder

(2023), Vol. 41, pp. 502-513, Neurotoxicity Research, C1

Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity

S Martin, T Connor, A Sanigorski, K McEwen, D Henstridge, B Nijagal, D De Souza, D Tull, P Meikle, G Kowalski, C Bruce, P Gregorevic, M Febbraio, F Collier, K Walder, S McGee

(2023), Vol. 14, pp. 1-13, Cell Death and Disease, Berlin, Germany, C1

Effects of antipsychotic drugs on energy metabolism

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, S Martin, T Truong, Z Liu, L Gray, G Kowalski, S McGee, J Kim, M Berk, K Walder

(2023), European Archives of Psychiatry and Clinical Neuroscience, Germany, C1

Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders

G Morris, K Walder, M Berk, A Carvalho, W Marx, C Bortolasci, A Yung, B Puri, M Maes

(2022), Vol. 114, pp. 1-17, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

Depression and bone loss as risk factors for cognitive decline: A systematic review and meta-analysis

K Mehta, S Thandavan, M Mohebbi, J Pasco, L Williams, K Walder, B Ng, V Gupta

(2022), Vol. 76, Ageing Research Reviews, C1

Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

G Morris, L Sominsky, K Walder, M Berk, W Marx, A Carvalho, C Bortolasci, M Maes, B Puri

(2022), Vol. 59, pp. 3485-3503, Molecular Neurobiology, Berlin, Germany, C1

Common effects of bipolar disorder medications on expression quantitative trait loci genes

T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, B Watmuff, J Kim, O Dean, M Richardson, M Berk, K Walder

(2022), Vol. 150, pp. 105-112, Journal of Psychiatric Research, C1

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder

T Truong, C Bortolasci, B Spolding, B Panizzutti, Z Liu, S Kidnapillai, M Richardson, L Gray, C Smith, O Dean, J Kim, M Berk, K Walder

(2022), Vol. 13, Frontiers in Pharmacology, C1

Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis

Z Liu, T Truong, C Bortolasci, B Spolding, B Panizzutti, C Swinton, J Kim, S Kidnapillai, M Richardson, L Gray, O Dean, S McGee, M Berk, K Walder

(2022), Vol. 23, International Journal of Molecular Sciences, C1

Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions

N Travica, H Aslam, A O'Neil, M Lane, M Berk, E Gamage, K Walder, Z Liu, T Segasby, W Marx

(2022), Vol. 193, Neurobiology of Learning and Memory, C1

Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs

T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, J Kim, O Dean, M Richardson, M Berk, K Walder

(2022), Vol. 23, International Journal of Molecular Sciences, C1

Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders

T Truong, B Panizzutti, J Kim, K Walder

(2022), Vol. 14, Pharmaceutics, C1

The role of metformin as a treatment for neuropsychiatric illness

S Dodd, L Sominsky, D Siskind, C Bortolasci, A Carvalho, M Maes, A Walker, K Walder, A Yung, L Williams, H Myles, T Watson, M Berk

(2022), Vol. 64, pp. 32-43, European Neuropsychopharmacology, Netherlands, C1

Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia

K Mehta, M Mohebbi, J Pasco, L Williams, K Walder, B Ng, V Gupta

(2022), Vol. 12, Scientific Reports, C1

Effects of psychoactive drugs on cellular bioenergetic pathways

C Bortolasci, B Spolding, S Kidnapillai, M Richardson, N Vasilijevic, S Martin, L Gray, S McGee, M Berk, K Walder

(2021), Vol. 22, pp. 79-93, World Journal of Biological Psychiatry, England, C1

Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity

Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, V Carr, M Berk, K Walder, M Green

(2021), Vol. 105, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

Chlamydial diversity and predictors of infection in a wild Australian parrot, the Crimson Rosella (Platycercus elegans)

H Stokes, J Martens, M Jelocnik, K Walder, Y Segal, M Berg, A Bennett

(2021), Vol. 68, pp. 487-498, Transboundary and Emerging Diseases, Germany, C1

Preventing the development of severe COVID-19 by modifying immunothrombosis

G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk

(2021), Vol. 264, Life Sciences, Netherlands, C1

Diet and depression: exploring the biological mechanisms of action

W Marx, M Lane, M Hockey, H Aslam, M Berk, K Walder, A Borsini, J Firth, C Pariante, K Berding, J Cryan, G Clarke, J Craig, K Su, D Mischoulon, F Gomez-Pinilla, J Foster, P Cani, S Thuret, H Staudacher, A Sánchez-Villegas, H Arshad, T Akbaraly, A O’Neil, T Segasby, F Jacka

(2021), Vol. 26, pp. 134-150, Molecular Psychiatry, England, C1

Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry

G Morris, A Walker, K Walder, M Berk, W Marx, A Carvalho, M Maes, B Puri

(2021), Vol. 58, pp. 2158-2182, Molecular Neurobiology, United States, C1

The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders

Gerwyn Morris, B Puri, C Bortolasci, Andre Carvalho, M Berk, K Walder, E Moreira, M Maes

(2021), Vol. 125, pp. 244-263, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

The endocannabinoid system and retinoic acid signaling combine to influence bone growth

D Fraher, R Mann, M Dubuisson, M Ellis, T Yu, K Walder, A Ward, C Winkler, Y Gibert

(2021), Vol. 529, Molecular and Cellular Endocrinology, Ireland, C1

Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: Efficacy, mechanisms of action, and factors influencing inter-individual response

G Morris, E Gamage, N Travica, M Berk, F Jacka, A O'Neil, B Puri, A Carvalho, C Bortolasci, K Walder, W Marx

(2021), Vol. 172, pp. 101-122, Free radical biology and medicine, Amsterdam, The Netherlands, C1

The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?

G Morris, C Bortolasci, B Puri, W Marx, A O'Neil, E Athan, K Walder, M Berk, L Olive, A Carvalho, M Maes

(2021), Vol. 144, Cytokine, England, C1

The lipid paradox in neuroprogressive disorders: causes and consequences

Gerwyn Morris, M Berk, K Walder, A O'Neil, M Maes, B Puri

(2021), Vol. 128, pp. 35-57, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

The endocannabinoidome in neuropsychiatry: Opportunities and potential risks

G Morris, K Walder, S Kloiber, P Amminger, M Berk, C Bortolasci, M Maes, B Puri, A Carvalho

(2021), Vol. 170, Pharmacological Research, Netherlands, C1

Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, G Morris, L Gray, J Kim, O Dean, M Berk, K Walder

(2021), Vol. 22, International Journal of Molecular Sciences, C1

Mood Regulatory Actions of Active and Sham Nucleus Accumbens Deep Brain Stimulation in Antidepressant Resistant Rats

R Kale, T Nguyen, J Price, N Yates, K Walder, M Berk, R Sillitoe, A Kouzani, S Tye

(2021), Vol. 15, Frontiers in Human Neuroscience, Switzerland, C1

Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial

C Bortolasci, A Turner, M Mohebbi, Z Liu, M Ashton, L Gray, W Marx, A Walker, G Kowalski, F Jacka, M Berk, O Dean, K Walder

(2021), Vol. 142, pp. 376-383, Journal of Psychiatric Research, England, C1

Biological mechanism(S) underpinning the association between antipsychotic drugs and weight gain

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, L Gray, J Kim, O Dean, M Berk, K Walder

(2021), Vol. 10, Journal of Clinical Medicine, C1

Beak and feather disease virus and Chlamydiales infections in wild Australian psittacines: no statistical evidence for dependence

J Martens, H Stokes, M Berg, K Walder, Y Segal, M Magrath, A Bennett

(2021), Vol. 121, pp. 333-339, Emu, C1

Exploring interleukin-6, lipopolysaccharide binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression

K Hasebe, M Mohebbi, L Gray, A Walker, C Bortolasci, A Turner, M Berk, K Walder, M Maes, B Kanchanatawan, M Ashton, L Berk, C Ng, G Malhi, A Singh, O Dean

(2021), Vol. 34, Acta Neuropsychiatrica, England, C1

The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder

S Kidnapillai, C Bortolasci, M Udawela, B Panizzutti, B Spolding, T Connor, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, E Scarr, M Leboyer, B Dean, M Berk, K Walder

(2020), Vol. 21, pp. 775-783, World Journal of Biological Psychiatry, England, C1

Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth

S Kidnapillai, B Wade, C Bortolasci, B Panizzutti, B Spolding, T Connor, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2020), Vol. 34, pp. 370-379, Journal of Psychopharmacology, United States, C1

Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis

C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean

(2020), Vol. 10, pp. e035080-, BMJ open, England, C1

Seasonal fluctuation of beak and feather disease virus (BFDV) infection in wild Crimson Rosellas (Platycercus elegans)

J Martens, H Stokes, M Berg, K Walder, A Bennett

(2020), Vol. 10, Scientific Reports, England, C1

A non-invasive method to assess environmental contamination with avian pathogens: beak and feather disease virus (BFDV) detection in nest boxes

J Martens, H Stokes, M Berg, K Walder, S Raidal, M Magrath, A Bennett

(2020), Vol. 2020, PeerJ, United States, C1

Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder

C Bortolasci, C Voigt, A Turner, M Mohebbi, L Gray, S Dodd, K Walder, M Berk, S Cotton, G Malhi, C Ng, N Dowling, J Sarris, O Dean

(2020), Vol. 32, pp. 313-320, Acta Neuropsychiatrica, England, C1

Beak and feather disease virus (BFDV) prevalence, load and excretion in seven species of wild caught common Australian parrots

J Martens, H Stokes, M Berg, K Walder, S Raidal, M Magrath, A Bennett

(2020), Vol. 15, PLoS ONE, United States, C1

Recombinant Balsamin induces apoptosis in liver and breast cancer cells via cell cycle arrest and regulation of apoptotic pathways

P Ajji, M Binder, K Walder, M Puri

(2020), Vol. 96, pp. 146-156, Process biochemistry, Amsterdam, The Netherlands, C1

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach

G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk

(2020), Vol. 258, Life Sciences, Netherlands, C1

Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

G Morris, E Athan, K Walder, C Bortolasci, A O'Neil, W Marx, M Berk, A Carvalho, M Maes, B Puri

(2020), Vol. 262, Life Sciences, Netherlands, C1

Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments

G Morris, B Puri, L Olive, A Carvalho, M Berk, K Walder, L Gustad, M Maes

(2020), Vol. 18, BMC Medicine, England, C1

Transcriptional effects of psychoactive drugs on genes involved in neurogenesis

C Bortolasci, B Spolding, S Kidnapillai, T Connor, T Truong, Z Liu, B Panizzutti, M Richardson, L Gray, M Berk, O Dean, K Walder

(2020), Vol. 21, pp. 1-19, International Journal of Molecular Sciences, C1

Species, sex and geographic variation in chlamydial prevalence in abundant wild Australian parrots

H Stokes, J Martens, K Walder, Y Segal, M Berg, A Bennett

(2020), Vol. 10, Scientific Reports, England, C1

Combination of Balsamin and Flavonoids Induce Apoptotic Effects in Liver and Breast Cancer Cells

P Ajji, K Walder, M Puri

(2020), Vol. 11, Frontiers in Pharmacology, Switzerland, C1

Prevalence of BFDV in wild breeding Platycercus elegans

J Eastwood, M Berg, R Ribot, K Buchanan, K Walder, A Bennett

(2019), Vol. 160, pp. 557-565, Journal of Ornithology, C1

The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia

M Ashton, O Dean, A Walker, C Bortolasci, C Ng, M Hopwood, B Harvey, M Möller, J McGrath, W Marx, A Turner, S Dodd, J Scott, J Khoo, K Walder, J Sarris, M Berk

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

Identification of Chlamydia gallinacea in a parrot and in free-range chickens in Australia

H Stokes, J Martens, A Chamings, K Walder, M Berg, Y Segal, A Bennett

(2019), Vol. 97, pp. 398-400, Australian veterinary journal, Chichester, Eng., C1

The compensatory antioxidant response system with a focus on neuroprogressive disorders

G Morris, B Puri, A Walker, M Berk, K Walder, C Bortolasci, W Marx, A Carvalho, M Maes

(2019), Vol. 95, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

Persistence of beak and feather disease virus (BFDV) infection in wild Crimson Rosellas (Platycercus elegans)

Johanne Martens, Helena Stokes, Justin Eastwood, Shane Raidal, Andrew Peters, Mathew Berg, Ken Walder, Michael Magrath, Andrew Bennett

(2019), Vol. 119, pp. 402-406, Emu - Austral ornithology, Abingdon, Eng., C1

Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline

K Hasebe, L Rivera, C Smith, T Allnutt, T Crowley, T Nelson, O Dean, S McGee, K Walder, L Gray

(2019), Vol. 82, pp. 309-318, Brain, Behavior, and Immunity, Netherlands, C1

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities

G Morris, B Puri, A Walker, M Maes, A Carvalho, K Walder, C Mazza, M Berk

(2019), Vol. 148, Pharmacological Research, Netherlands, C1

Drugs used in the treatment of bipolar disorder and their effects on cholesterol biosynthesis - a possible therapeutic mechanism

S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

G Morris, B Puri, A Walker, M Maes, A Carvalho, C Bortolasci, K Walder, M Berk

(2019), Vol. 107, pp. 862-882, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

ENACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

S Cotton, M Berk, A Watson, S Wood, K Allott, C Bartholomeusz, C Bortolasci, K Walder, B O'Donoghue, O Dean, A Chanen, G Amminger, P McGorry, A Burnside, J Uren, A Ratheesh, S Dodd

(2019), Vol. 20, Trials, England, C1

The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases

G Morris, K Walder, A Carvalho, S Tye, K Lucas, M Berk, M Maes

(2018), Vol. 84, pp. 453-469, Neuroscience and Biobehavioral Reviews, United States, C1

Mechanisms underpinning the polypharmacy effects of medications in psychiatry

C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder

(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1

Purification and functional characterization of recombinant balsamin, a ribosome-inactivating protein from Momordica balsamina

Parminder Ajji, Shailendra Sonkar, Ken Walder, Munish Puri

(2018), Vol. 114, pp. 226-234, International journal of biological macromolecules, Amsterdam, The Netherlands, C1

The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications

G Morris, B Puri, K Walder, M Berk, B Stubbs, M Maes, A Carvalho

(2018), Vol. 55, pp. 8765-8787, Molecular Neurobiology, United States, C1

Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression

J Price, Carrie Bronars, Sophie Erhardt, Kathyrn Cullen, Lilly Schwieler, Michael Berk, Ken Walder, Sean McGee, Mark Frye, Susannah Tye

(2018), Vol. 90, pp. 212-220, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding

J Czeczor, A Genders, K Aston-Mourney, T Connor, L Hall, K Hasebe, M Ellis, K De Jong, D Henstridge, P Meikle, M Febbraio, K Walder, S McGee

(2018), Vol. 237, pp. 311-322, Journal of Endocrinology, England, C1

The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis

G Morris, B Stubbs, C Köhler, K Walder, A Slyepchenko, M Berk, A Carvalho

(2018), Vol. 41, pp. 255-265, Sleep Medicine Reviews, England, C1

Diet during Pregnancy is Implicated in the Regulation of Hypothalamic RNA Methylation and Risk of Obesity in Offspring

A Kaspi, I Khurana, M Ziemann, T Connor, B Spolding, P Zimmet, K Walder, A El-Osta

(2018), Vol. 62, Molecular Nutrition and Food Research, Germany, C1

Pair fidelity in long-lived parrots: genetic and behavioural evidence from the Crimson Rosella ( Platycercus elegans )

Justin Eastwood, Mathew Berg, Raoul Ribot, Helena Stokes, Johanne Martens, Katherine Buchanan, Ken Walder, Andrew Bennett

(2018), Vol. 118, pp. 369-374, Emu: Austral ornithology, Abingdon, Eng., C1

Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression

B Panizzutti, C Bortolasci, K Hasebe, S Kidnapillai, L Gray, K Walder, M Berk, M Mohebbi, S Dodd, C Gama, P Magalhães, S Cotton, F Kapczinski, A Bush, G Malhi, O Dean

(2018), Vol. 30, pp. 334-341, Acta Neuropsychiatrica, England, C1

Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases

R Chaudhary, K Walder, C Hagemeyer, J Kanwar

(2018), Vol. 20, Current Atherosclerosis Reports, United States, C1

Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome

G Morris, M Berk, H Klein, K Walder, P Galecki, M Maes

(2017), Vol. 54, pp. 4271-4291, Molecular Neurobiology, United States, C1

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, K Walder, M Maes

(2017), Vol. 54, pp. 4432-4451, Molecular Neurobiology, United States, C1

Gene expression signature: A powerful approach for drug discovery in diabetes

S Sithara, T Crowley, K Walder, K Aston-Mourney

(2017), Vol. 232, pp. R131-R139, Journal of Endocrinology, England, C1

A model of the mitochondrial basis of bipolar disorder

G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk

(2017), Vol. 74, pp. 1-20, Neuroscience and Biobehavioral Reviews, United States, C1

Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice

V Gaur, T Connor, K Venardos, D Henstridge, S Martin, C Swinton, S Morrison, K Aston-Mourney, S Gehrig, R van Ewijk, G Lynch, M Febbraio, G Steinberg, M Hargreaves, K Walder, S McGee

(2017), Vol. 19, pp. 936-943, Diabetes, Obesity and Metabolism, England, C1

Lysine post-translational modification of glyceraldehyde-3-phosphate dehydrogenase regulates hepatic and systemic metabolism

S Bond, K Howlett, G Kowalski, S Mason, T Connor, A Cooper, V Streltsov, C Bruce, K Walder, S McGee

(2017), Vol. 31, pp. 2592-2602, FASEB journal, Bethesda, Md., C1

Adjunctive N-acetylcysteine in depression: Exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean

(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1

Exercise and the skeletal muscle epigenome

S McGee, K Walder

(2017), Vol. 7, Cold Spring Harbor Perspectives in Medicine, United States, C1

Balsamin induces apoptosis in breast cancer cells via DNA fragmentation and cell cycle arrest

P Ajji, M Binder, K Walder, M Puri

(2017), Vol. 432, pp. 189-198, Molecular and Cellular Biochemistry, Netherlands, C1

Validation of a Portable Low-Power Deep Brain Stimulation Device Through Anxiolytic Effects in a Laboratory Rat Model

A Kouzani, R Kale, P Zarate-Garza, M Berk, K Walder, S Tye

(2017), Vol. 25, pp. 1365-1374, IEEE Transactions on Neural Systems and Rehabilitation Engineering, United States, C1

Hypothalamic gene expression is regulated by DNA methylation linking parental diet during pregnancy to offspring's risk of obesity in psammomys obesus

I Khurana, A Kaspi, M Ziemann, T Block, T Connor, B Spolding, A Cooper, P Zimmet, A El-Osta, K Walder

(2017), Vol. 49, pp. S103-S104, Pathology, Amsterdam, The Netherlands, C1

The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases

G Morris, M Berk, P Galecki, K Walder, M Maes

(2016), Vol. 53, pp. 1195-1219, Molecular Neurobiology, United States, C1

The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability

G Morris, M Berk, K Walder, M Maes

(2016), Vol. 53, pp. 2550-2571, Molecular Neurobiology, United States, C1

The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling : new drug targets in neuroimmune disorders

G Morris, K Walder, B Puri, M Berk, M Maes

(2016), Vol. 53, pp. 4638-4658, Molecular neurobiology, New York, N.Y., C1

Citalopram and sertraline exposure compromises embryonic bone development

D Fraher, J Hodge, F Collier, J McMillan, R Kennedy, M Ellis, G Nicholson, K Walder, S Dodd, M Berk, J Pasco, L Williams, Y Gibert

(2016), Vol. 21, pp. 656-664, Molecular Psychiatry, England, C1

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

R Chaudhary, K Roy, R Kanwar, K Walder, J Kanwar

(2016), Vol. 14, Journal of Nanobiotechnology, England, C1

Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis

M Coughlan, G Higgins, T Nguyen, S Penfold, V Thallas-Bonke, S Tan, G Ramm, N Van Bergen, D Henstridge, K Sourris, B Harcourt, I Trounce, P Robb, A Laskowski, S McGee, A Genders, K Walder, B Drew, P Gregorevic, H Qian, M Thomas, G Jerums, R Macisaac, A Skene, D Power, E Ekinci, X Wijeyeratne, L Gallo, M Herman-Edelstein, M Ryan, M Cooper, D Thorburn, J Forbes

(2016), Vol. 65, pp. 1085-1098, Diabetes, United States, C1

DNA methylation regulates hypothalamic gene expression linking parental diet during pregnancy to the offspring's risk of obesity in Psammomys obesus

I Khurana, A Kaspi, M Ziemann, T Block, T Connor, B Spolding, A Cooper, P Zimmet, A El-Osta, K Walder

(2016), Vol. 40, pp. 1079-1088, International Journal of Obesity, England, C1

Functional analysis of a Type-I ribosome inactivating protein balsamin from Momordica balsamina with anti-microbial and DNase activity

P Ajji, K Walder, M Puri

(2016), Vol. 71, pp. 265-271, Plant foods for human nutrition, New York, N.Y., C1

Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects

Y Kim, S McGee, J Czeczor, A Walker, R Kale, A Kouzani, K Walder, M Berk, S Tye

(2016), Vol. 6, pp. e842-, Translational psychiatry, United States, C1

Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation

V Gaur, T Connor, A Sanigorski, S Martin, C Bruce, D Henstridge, S Bond, K McEwen, L Kerr-Bayles, T Ashton, C Fleming, M Wu, L Pike Winer, D Chen, G Hudson, J Schwabe, K Baar, M Febbraio, P Gregorevic, F Pfeffer, K Walder, M Hargreaves, S McGee

(2016), Vol. 16, pp. 2802-2810, Cell Reports, United States, C1

Pathways of Acetyl-CoA Metabolism Involved in the Reversal of Palmitate-Induced Glucose Production by Metformin and Salicylate

B Hayward, J Molero, K Windmill, A Sanigorski, J Weir, N McRae, K Aston-Mourney, B Osborne, B Liao, K Walder, P Meikle, N Konstantopoulos, C Schmitz-Peiffer

(2016), Vol. 124, pp. 602-612, Experimental and Clinical Endocrinology and Diabetes, Germany, C1

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level.

L Zabeau, C Jensen, S Seeuws, K Venken, A Verhee, D Catteeuw, G van Loo, H Chen, K Walder, J Hollis, S Foote, M Morris, J Van der Heyden, F Peelman, B Oldfield, J Rubio, D Elewaut, J Tavernier

(2015), Vol. 72, pp. 629-644, Cellular and Molecular Life Sciences, Switzerland, C1

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

G Morris, M Berk, K Walder, M Maes

(2015), Vol. 13, pp. 1-23, BMC Medicine, London, Eng., C1

Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy

E Callaly, K Walder, G Morris, M Maes, M Debnath, M Berk

(2015), Vol. 15, pp. 355-365, Mini-reviews in medicinal chemistry, Amsterdam, The Netherlands, C1

Prevalence of beak and feather disease virus in wild Platycercus elegans: comparison of three tissue types using a probe-based real-time qPCR test

J Eastwood, M Berg, B Spolding, K Buchanan, A Bennett, K Walder

(2015), Vol. 63, pp. 1-8, Australian journal of zoology, Clayton, Vic., C1

Evolution of optogenetic microdevices

R Kale, A Kouzani, K Walder, M Berk, S Tye

(2015), Vol. 2, pp. 1-11, Neurophotonics, Bellingham, W.A., C1

Lipid abundance in zebrafish embryos is regulated by complementary actions of the endocannabinoid system and retinoic acid pathway

D Fraher, M Ellis, S Morrison, S McGee, A Ward, K Walder, Y Gibert

(2015), Vol. 156, pp. 3596-3609, Endocrinology, Bethesda, Md., C1

CXCR4 Antagonism attenuates the development of diabetic cardiac fibrosis

P Chu, K Walder, D Horlock, D Williams, E Nelson, M Byrne, K Jandeleit-Dahm, P Zimmet, D Kaye

(2015), Vol. 10, pp. 1-13, PLoS One, San Francisco, CA, C1

Wireless optogenetics: an exploration of portable microdevices for small animal photostimulation

R Kale, A Kouzani, M Berk, K Walder, J Berk, S Tye

(2015), Vol. 20, pp. 225-230, Procedia technology, Amsterdam, The Netherlands, C1

Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli Sand Rat)

B Spolding, T Connor, C Wittmer, L Abreu, A Kaspi, M Ziemann, G Kaur, A Cooper, S Morrison, S Lee, A Sinclair, Y Gibert, J Trevaskis, J Roth, A El-Osta, R Standish, K Walder

(2014), Vol. 9, pp. 1-7, PLoS one, San Francisco, Calif., C1

Phylogenetic analysis of beak and feather disease virus across a host ring-species complex

J Eastwood, M Berg, R Ribot, S Raidal, K Buchanan, K Walder, A Bennett

(2014), Vol. 111, pp. 14153-14158, Proceedings of the national scademy of sciences of the USA, Washington, DC, C1

Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

R Simpson, G Nicholson, J Proietto, A Sarah, K Sanders, G Phillips, J Chambers, R MacGinley, N Orford, K Walder, G Krippner, K Skoff, V Wacher

(2014), Vol. 37, pp. 3121-3123, Diabetes Care, Alexandria VA., C1

Non-referenced genome assembly from epigenomic short-read data

A Kaspi, M Ziemann, S Keating, I Khurana, T Connor, B Spolding, A Cooper, R Lazarus, K Walder, P Zimmet, A El-Osta

(2014), Vol. 9, pp. 1329-1338, Epigenetics, United States, C1

Genetic variation associated with hypersensitivity to mercury.

D Austin, B Spolding, S Gondalia, K Shandley, E Palombo, S Knowles, K Walder

(2014), Vol. 21, pp. 236-241, Toxicology International, India, C1-1

Genetic basis for the increased expression of vacuolar H+ translocating ATPase genes upon imatinib treatment in human lymphoblastoid cells

H Kulkarni, H Goring, J Curran, V Diego, T Dyer, S Cole, K Walder, G Collier, J Blangero, M Carless

(2013), Vol. 71, pp. 1095-1100, Cancer chemotherapy and pharmacology, Heidelberg, Germany, C1

Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

A Walker, S Burnett, K Hasebe, J McGillivray, L Gray, S McGee, K Walder, M Berk, S Tye

(2013), Vol. 242, pp. 76-83, Behavioural brain research, Amsterdam, The Netherlands, C1

Targeted multimodal liposomes for nano-delivery and imaging: an avenger for drug resistance and cancer.

S Gurudevan, R Kanwar, R Veedu, S Sasidharan, R Kennedy, K Walder, N Prasad, J Kanwar

(2013), Vol. 13, pp. 322-334, Current gene therapy, Bussum, The Netherlands, C1

The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes

K Bolton, D Segal, K Walder

(2012), Vol. 6, pp. 67-72, Biologics : targets and therapy, Auckland, New Zealand, C1

Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo

N Konstantopoulos, J Molero, S McGee, B Spolding, T Connor, M de Vries, S Wanyonyi, R Fahey, S Morrison, C Swinton, S Jones, A Cooper, L Garcia-Guerra, V Foletta, G Krippner, S Andrikopoulos, K Walder

(2012), Vol. 61, pp. 2146-2154, Diabetes, Alexandria, Va., C1

Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines

H Kulkarni, H Goring, V Diego, S Cole, K Walder, G Collier, J Blangero, M Carless

(2012), Vol. 5, pp. 1-12, BMC medical genomics, London, England, C1

Genetic variation in SH3-domain GRB2-like (endophilin)-interacting protein 1 has a major impact on fat mass

N Cummings, K Shields, J Curran, K Bozaoglu, J Trevaskis, K Gluschenko, G Cai, A Comuzzie, T Dyer, K Walder, P Zimmet, G Collier, J Blangero, J Jowett

(2012), Vol. 36, pp. 201-206, International journal of obesity, London, England, C1

A gene expression signature for insulin resistance

N Konstantopoulos, V Foletta, D Segal, K Shields, A Sanigorski, K Windmill, C Swinton, T Connor, S Wanyonyi, T Dyer, R Fahey, R Watt, J Curran, J Molero, G Krippner, G Collier, D James, J Blangero, J Jowett, K Walder

(2011), Vol. 43, pp. 110-120, Physiological genomics, Bethesda, Md., C1

Deficiency in interferon-y results in reduced body weight and better glucose tolerance in mice

N Wong, B Fam, G Cempako, G Steinberg, K Walder, T Kay, J Proietto, S Andrikopoulos

(2011), Vol. 152, pp. 3690-3699, Endocrinology, Chevy Chase, Md., C1

Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus

J Molero, S Lee, I Leizerman, A Chajut, A Cooper, K Walder

(2010), Vol. 1802, pp. 235-239, B B A - Molecular Basis of Disease, Amsterdam, The Netherlands, C1

Genetic variation in PARL influences mitochondrian content

J Curran, J Jowett, L Abraham, L Diepeveen, K Elliott, T Dyer, L Kerr-Bayles, M Johnson, A Comuzzie, E Moses, K Walder, G Collier, J Blangero, A Kissebah

(2010), Vol. 127, pp. 183-190, Human genetics, Heidelberg, Germany, C1

The characterisation of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndrome

M Prior, V Foletta, J Jowett, D Segal, M Carless, J Curran, T Dyer, E Moses, A McAinch, N Konstantopoulos, K Bozaoglu, G Collier, D Cameron-Smith, J Blangero, K Walder

(2010), Vol. 59, pp. 1057-1064, Metabolism, Philadelphia, Pa., C1

Chemerin, a novel adipokine in the regulation of angiogenesis

K Bozaoglu, J Curran, C Stocker, M Zaibi, D Segal, N Konstantopoulos, S Morrison, M Carless, T Dyer, S Cole, H Goring, E Moses, K Walder, M Cawthorne, J Blangero, J Jowett

(2010), Vol. 95, pp. 2476-2485, Journal of clinical endocrinology & metabolism, Chevy Chase, Md., C1

Regulation of skeletal muscle oxidative capacity and insulin signaling by the Mitochondrial Rhomboid Protease PARL

A Civitarese, P MacLean, S Carling, L Kerr-Bayles, R McMillan, A Pierce, T Becker, C Moro, J Finlayson, N Lefort, C Newgard, L Mandarino, W Cefalu, K Walder, G Collier, M Hulver, S Smith, E Ravussin

(2010), Vol. 11, pp. 412-426, Cell metabolism, Cambridge, Mass., C1

NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors

V Foletta, M Prior, N Stupka, K Carey, D Segal, S Jones, C Swinton, S Martin, D Cameron-Smith, K Walder

(2009), Vol. 587, pp. 1619-1634, Journal of physiology, Oxford, England, C1

RTKN2 induces NF-KappaB dependent resistance to intrinsic apoptosis in HEK cells and REgulates BCL-2 genes in human CD4+ lymphocytes

F Collier, A Loving, A Baker, J McLeod, K Walder, M Kirkland

(2009), Vol. 2, pp. 9-23, Journal of cell death, Auckland, New Zealand, C1

Identification of secreted proteins associated with obesity and type 2 diabetes in Psammomys obesus

K Bolton, D Segal, J McMillan, A Sanigorski, G Collier, K Walder

(2009), Vol. 33, pp. 1-13, International journal of obesity, Hampshire, England, C1

Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity

H Su, J Gunter, M de Vries, T Connor, S Wanyonyi, F Newell, D Segal, J Molero, O Reizes, J Prins, L Hutley, K Walder, J Whitehead

(2009), Vol. 386, pp. 351-355, Biochemical and biophysical research communications, San Diego, Calif., C1

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

K Bozaoglu, D Segal, K Shields, N Cummings, J Curran, A Comuzzie, M Mahaney, D Rainwater, J VandeBerg, J MacCluer, G Collier, J Blangero, K Walder, J Jowett

(2009), Vol. 94, pp. 3085-3088, The Journal of Clinical Endocrinology & Metabolism, Philadelphia, PA, C1

Enhanced proliferation of human skeletal muscle precursor cells derived from elderly donors cultured in estimated physiological (5%) oxygen

S Martin, F Collier, M Kirkland, K Walder, N Stupka

(2009), Vol. 61, pp. 93-107, Cytotechnology: international journal of cell culture and biotechnology, Dordrecht, Netherlands, C1

Decorin is a secreted protein associated with obesity and type 2 diabetes

K Bolton, D Segal, J McMillan, J Jowett, L Heilbronn, K Abberton, P Zimmet, D Chisholm, G Collier, K Walder

(2008), Vol. 32, pp. 1113-1121, International journal of obesity, London, England, C1-1

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

K Bozaoglu, K Bolton, J McMillan, P Zimmet, J Jowett, G Collier, K Walder, D Segal

(2007), Vol. 148, pp. 4687-4694, Endocrinology, Los Angeles, Calif., C1

Localization and expression of selenoprotein S in the testis of Psammomys obesus

K Windmill, J Tenne-Brown, R Bayles, J Trevaskis, Y Gao, K Walder

(2007), Vol. 38, pp. 97-101, Journal of molecular histology, Amsterdam, The Netherlands, C1

SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis

K Kim, Y Gao, K Walder, G Collier, J Skelton, A Kissebah

(2007), Vol. 354, pp. 127-132, Biochemical and biophysical research communications, Orlando, Fla., C1

Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells

Y Gao, J Pagnon, H Feng, N Konstantopoulos, J Jowett, K Walder

(2007), Vol. 356, pp. 636-641, Biochemical and biophysical research communications, Orlando, Fla., C1

Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays

K Carey, D Segal, R Klein, A Sanigorski, K Walder, G Collier, D Cameron-Smith

(2006), Vol. 56, pp. 246-255, Pathology international, Carlton South, Vic, C1

Activation of the selenopritein SEPS1 gene expression by pro-inflammatory cytokines in Hep G2 cells

Y Gao, N Hannan, S Wanyonyi, N Konstantopoulos, J Pagnon, H Feng, J Jowett, K Kim, K Walder, G Collier

(2006), Vol. 33, pp. 246-251, Cytokine, Amsterdam, The Netherlands, C1

Association of genetic vatiation within UBL5 with phenotypes of metabolic syndrome

K Bozaoglu, J Curran, K Elliott, K Walder, T Dyer, D Rainwater, J Vandenberg, A Comuzzie, G Collier, P Zimmet, J Maccluer, J Jowett, J Blangero

(2006), Vol. 78, pp. 147-159, Human biology, Detroit, Mich., C1

The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes

K Walder, L Kerr-Bayles, A Civitarese, J Jowett, J Curran, K Elliott, J Trevaskis, N Bishara, P Zimmet, L Mandarino, E Ravussin, J Blangero, A Kissebah, G Collier

(2005), Vol. 48, pp. 459-468, Diabetologia, Berlin , Germany, C1

Genetic variation in selenoprotein S influences inflammatory response

J Curran, J Jowett, K Elliott, Y Gao, K Gluschenko, W Jianmin, D Azim, G Cai, M Mahaney, A Comuzzie, T Dyer, K Walder, P Zimmet, J MacCluer, G Collier, A Kissebah, J Blangero

(2005), Vol. 37, pp. 1234-1241, Nature genetics, New York, N.Y., C1-1

Src homology 3-domain growth factor receptor-bound 2-like (endophilin) interacting protein 1, a novel neuronal protein that regulates energy balance

J Trevaskis, K Walder, V Foletta, L Kerr-Bayles, J McMillan, A Cooper

(2005), Vol. 146, pp. 3757-3764, Endocrinology, Philadelphia, Pa., C1-1

PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle

R Southgate, C Bruce, A Carey, G Steinberg, K Walder, R Monks, M Watt, J Hawley, M Birnbaum, M Febbraio

(2005), Vol. 19, pp. 2072-2074, The FASEB journal : official publication of the Federation of American Societies for experimental biology, Bethesda, Md., C1-1

Identification and characterization of a lymphocytic Rho-GTPase effector: rhotekin-2

F Collier, C Gregorio-King, T Gough, C Talbot, K Walder, M Kirkland

(2004), Vol. 324, pp. 1360-1369, Biochemical and biophysical research communications, San Diego, Calif., C1

Identification of hypothalamic genes implicated in the development of obesity in Psammomys obesus using differential display PCR

J Trevaskis, J McMillan, K Windmill, K Walder, G Collier

(2004), Vol. 137, pp. 65-73, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, Tarrytown, N.Y., C1

Regulation of selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress - SelS is a novel glucose-regulated protein

Y Gao, H Feng, K Walder, K Bolton, T Sunderland, N Bishara, M Quick, L Kantham, G Collier

(2004), Vol. 563, pp. 185-190, FEBS letters, Amsterdam, Netherlands, C1

c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action

J Molero, T Jensen, P Withers, M Couzens, H Herzog, C Thien, W Langdon, K Walder, M Murphy, D Bowtell, D James, G Cooney

(2004), Vol. 114, pp. 1326-1333, Journal of clinical investigation, New York, N.Y., C1

Genetic variation in BEACON influences quantitative variation in metabolic syndrome-related phenotypes

J Jowett, K Elliott, J Curran, N Hunt, K Walder, G Collier, P Zimmet, J Blangero

(2004), Vol. 53, pp. 2467-2472, Diabetes, Alexandria, Va., C1

Obesity and diabetes gene discovery approaches

K Walder, D Segal, J Jowett, J Blangero, G Collier

(2003), Vol. 9, pp. 1357-1372, Current pharmaceutical design, Schiphol, Netherlands, C1

Genetic studies in Psammomys obesus

K Walder, D Segal, J Jowett, J Blangero, P Zimmet, G Collier

(2003), Vol. 9, pp. 275-278, Progress in obesity research, Eastleigh, England, C1

Transcriptional profiling and gene discovery

G Collier, A De Silva, J Tenne-Brown, A Sanigorski, D Segal, L Kantham, K Walder

(2003), Vol. 9, pp. 36-39, Progress in obesity research, London, England, C1

Elevation in tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells

Y Gao, K Walder, T Sunderland, L Kantham, H Feng, M Quick, N Bishara, A De Silva, G Augert, J Tenne-Brown, G Collier

(2003), Vol. 52, pp. 929-934, Diabetes, New York, N.Y., C1

The taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity

A Southon, K Walder, A Sanigorski, P Zimmet, G Nicholson, M Kotowicz, G Collier

(2003), Vol. 16, pp. 72-76, Diabetes, nutrition & metabolism, Milano, Italy, C1

Beacon interacts with cdc2/cdc28-like kinases

L Kantham, L Kerr-Bayles, N Godde, M Quick, R Webb, T Sunderland, J Bond, K Walder, G Augert, G Collier

(2003), Vol. 304, pp. 125-129, Biochemical and biophysical research communications, New York, N.Y., C1

ORP3 splice variants and their expression in human tissues and hematopoietic cells

F Collier, C Gregorio-King, J Apostolopoulos, K Walder, M Kirkland

(2003), Vol. 22, pp. 1-9, DNA and cell biology, New Rochelle, N.Y., C1-1

Tanis: a link between type 2 diabetes and inflammation?

K Walder, L Kantham, J McMillan, J Trevaskis, L Kerr, A de Silva, T Sunderland, N Godde, Y Gao, N Bishara, K Windmill, J Tenne-Brown, G Augert, P Zimmet, G Collier

(2002), Vol. 51, pp. 1859-1866, Diabetes, New York, N.Y., C1

Elevated hypothalamic beacon gene expression in Psammomys obesus prone to develop obesity and type 2 diabetes

K Walder, E Ziv, R Kalman, K Whitecross, E Shafrir, P Zimmet, G Collier

(2002), Vol. 26, pp. 605-609, International journal of obesity, London, England, C1

Calpain 3 gene expression in skeletal muscle is associated with body fat content and measures of insulin resistance

K Walder, J McMillan, N Lapsys, A Kriketos, J Trevaskis, A Civitarese, A Southon, P Zimmet, G Collier

(2002), Vol. 26, pp. 442-449, International journal of obesity, London, England, C1

New approaches to gene discovery with animal models of obesity and diabetes

G Collier, K Walder, A De Silva, J Tenne-Brown, A Sanigorski, D Segal, L Kantham, G Augert

(2002), Vol. 967, pp. 403-413, Annals of the New York academy of science, New York, N.Y., C1

A custom-built insulin resistance gene chip

K Walder, D Segal, S Chehab, G Augert, D Cameron-Smith, M Hargreaves, G Collier

(2002), Vol. 967, pp. 274-282, Annals of the New York Academy of Sciences, New York, N.Y., C1

Effects of beacon administration on energy expenditure and substrate utilisation in Psammomys obesus (Israeli sand rats)

K Walder, J McMillan, S Lee, A Civitarese, P Zimmet, G Collier

(2001), Vol. 25, pp. 1281-1285, International journal of obesity, London, England, C1

Genetic variation and obesity in Australian women: A prospective study.

A De Silva, K Walder, E Boyko, K Whitecross, G Nicholson, M Kolowitz, J Pasco, G Collier

(2001), Vol. 9, pp. 733-740, Obesity, Silver Spring, Md., C1

AFLP fingerprinting of the human genome

M Prochazka, K Walder, J Xia

(2001), Vol. 108, pp. 59-65, Human genetics, Berlin, Germany, C1-1

Impact of obesity and leptin treatment on adipocyte gene expression in Psammomys obesus

A Sanigorski, D Cameron-Smith, P Lewandowski, K Walder, A de Silva, G Morton, G Collier

(2000), Vol. 164, pp. 45-50, Journal of endocrinology, Bristol, England, C1-1

Beacon: a novel gene involved in the regulation of energy balance

G Collier, J McMillan, K Windmill, K Walder, J Tenne-Brown, A de Silva, J Trevaskis, S Jones, G Morton, S Lee, G Augert, A Civitarese, P Zimmet

(2000), Vol. 49, pp. 1766-1771, Diabetes, Arlington, Va., C1-1

Leptin and the treatment of obesity

K Walder, A De Silva

(2000), Vol. 51, pp. 66-79, Drug Development Research, Hoboken, N.J., C1-1

Leptin resistance in a polygenic, hyperleptinemic animal model of obesity and NIDDM : Psammomys obesus

K Walder, P Lewandowski, G Morton, A Sanigorski, A de Silva, P Zimmet, G Collier

(1999), Vol. 23, pp. 83-89, International journal of obesity, London, England, C1-1

Dysregulation of leptin in response to fasting in insulin-resistant Psammomys obesus (Israeli sand rats)

K Walder, S Lee, P Zimmet, G Collier

(1998), Vol. 47, pp. 125-128, Metabolism, Amsterdam, The Netherlands, C1-1

Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians

K Walder, R Norman, R Hanson, P Schrauwen, M Neverova, C Jenkinson, J Easlick, C Warden, C Pecqueur, S Raimbault, D Ricquier, M Harper, K Silver, A Shuldiner, G Solanes, B Lowell, W Chung, R Leibel, R Pratley, E Ravussin

(1998), Vol. 7, pp. 1431-1435, Human molecular genetics, London, Eng., C1-1

Leptin and the development of obesity and diabetes in Psammomys obesus

G Collier, K Walder, P Lewandowski, A Sanigorski, P Zimmet

(1997), Vol. 5, pp. 455-458, Obesity research, Silver Spring, Md., C1-1

Disproportionate increase of fatty acid binding proteins in the livers of obese diabetic Psammomys obesus

P Lewandowski, D Cameron-Smith, K Moulton, K Walder, A Sanigorski, G Collier

(1997), Vol. 827, pp. 536-540, Annals of the New York academy of sciences, Hoboken, N. J., C1-1

The effect of dietary energy restriction on body weight gain and the development of noninsulin-dependent diabetes mellitus (NIDDM) in Psammomys obesus

K Walder, C Dascaliuc, P Lewandowski, A Sanigorski, P Zimmet, G Collier

(1997), Vol. 5, pp. 193-200, Obesity research, London, England, C1-1

Development of obesity and insulin resistance in the Israeli sand rat (Psammomys obesus). Does leptin play a role?

G Collier, A De Silva, A Sanigorski, K Walder, A Yamamoto, P Zimmet

(1997), Vol. 827, pp. 50-63, Annals of the New York Academy of Sciences, Chichester, Eng., C1-1

Ob (obese) gene expression and leptin levels in Psammomys obesus

K Walder, M Willet, P Zimmet, G Collier

(1997), Vol. 1354, pp. 272-278, Biochimica et biophysica acts, Amsterdam, The Netherlands, C1-1

Non-insulin dependent diabetes mellitus in Psammomys obesus is independent of changes in tissue fatty acid composition

G Collier, F Collier, A Sanigorski, K Walder, D Cameron-Smith, A Sinclair

(1997), Vol. 32, pp. 317-322, Lipids, Berlin, Germany, C1-1

Diabetes, obesity and leptin in the Israeli sand rat (Psammomys obesus)

G Collier, K Walder, A De Silva, G Morton, P Zimmet

(1997), Vol. 105, pp. 36-37, Experimental and Clinical Endocrinology and Diabetes, C1-1

Effect of coingestion of fat and protein with carbohydrate feedings on muscle glycogen storage

L Burke, G Collier, S Beasley, P Davis, P Fricker, P Heeley, K Walder, M Hargreaves

(1995), Vol. 78, pp. 2187-2192, Journal of applied physiology, Bethesda, Md., C1-1